InVivo
UPDATE: InVivo Therapeutics prices public offering at $7.50 per share to raise $28 million
March 15, 2016Business Services, Manufacturing and Production, Sales and Marketing InVivo, Share price, Stake sale
InVivo Therapeutics (Nasdaq: NVIV) on Tuesday said it plans to raise about $28 million via a public offering of over …
Latest content
Highlighting the value of lab research for healthcare innovation
November 2, 2026
Medtronic secures CE Mark for new cardiac pacing portfolio
October 30, 2026
Dermatology leader Doncker is new Onicor CEO
October 29, 2026
